February 27, 2026

Beta Bionics, Inc. (BBNX) Stock Analysis: Exploring a Potential 79.85% Upside in Healthcare Innovation

Beta Bionics, Inc. (NASDAQ: BBNX), a promising name in the healthcare sector, is capturing attention with its innovative approach to diabetes management. With its current market..

Standard BioTools Inc. (LAB) Stock Analysis: Unveiling a 32% Upside Potential Amidst Challenging Metrics

For investors with a keen eye on the healthcare sector, Standard BioTools Inc. (NASDAQ: LAB) presents a fascinating case study. Despite its current standing in the..

Precigen, Inc. (PGEN) Stock Analysis: Unveiling a 123% Upside Potential in Biotech

For investors with a keen eye on the biotechnology sector, Precigen, Inc. (NASDAQ: PGEN) presents a compelling opportunity. With a market capitalization of $1.35 billion, this..

Keros Therapeutics, Inc. (KROS) Investor Outlook: Exploring the 53% Potential Upside

Keros Therapeutics, Inc. (NASDAQ: KROS) presents an intriguing opportunity within the biotechnology sector, particularly for investors seeking growth in innovative healthcare solutions. As a clinical-stage biopharmaceutical..

SIGA Technologies Inc. (SIGA) Stock Analysis: A Healthcare Contender with Strong Return on Equity

Investors with an eye on the healthcare sector might find SIGA Technologies Inc. (NASDAQ: SIGA) an intriguing prospect. This specialty drug manufacturer, headquartered in New York,..

Taysha Gene Therapies, Inc. (TSHA): Analyst Ratings Signal Potential 140% Upside in Biotech Stock

Taysha Gene Therapies, Inc. (NASDAQ: TSHA) is capturing investor attention with its impressive potential upside of 140.70%, as suggested by a robust consensus from analysts. As..

Replimune Group, Inc. (REPL) Stock Analysis: A High-Potential Biotech Play with 67% Upside

Replimune Group, Inc. (NASDAQ: REPL) is capturing the attention of investors with its innovative approach to cancer treatment, aiming to revolutionize the field of oncolytic immunotherapy...

Semler Scientific, Inc. (SMLR) Stock Analysis: Examining the 258% Potential Upside for Investors

Semler Scientific, Inc. (NASDAQ: SMLR), a prominent player in the medical devices sector, is currently capturing investor attention with its remarkable potential upside of 258.65%. This..

Claritev Corporation (CTEV) Stock Analysis: Exploring a 215% Potential Upside in Healthcare Data Solutions

Claritev Corporation (CTEV), a dynamic player in the healthcare sector, is drawing attention with a striking potential upside of 215.81%. Specializing in health information services, Claritev..

Celcuity Inc. (CELC)

⚠️ No article content returned.

..

Immunome, Inc. (IMNM) Investor Outlook: Exploring a Promising 60% Upside in the Biotech Sector

Immunome, Inc. (IMNM), a United States-based clinical-stage biotechnology company, has been making waves in the healthcare sector with its innovative approach to developing targeted cancer therapies...

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Evaluating the 13.23% Potential Upside for Investors

For investors eyeing opportunities in the healthcare sector, Cross Country Healthcare, Inc. (NASDAQ: CCRN) presents an intriguing case. Specializing in providing talent management services for healthcare..

CeriBell, Inc. (CBLL) Stock Analysis: Exploring a 43% Potential Upside in the Innovative Medical Devices Sector

CeriBell, Inc. (CBLL) is making waves in the healthcare sector with its pioneering approach to neurological diagnostics. As a medical technology company specializing in the development..

Eton Pharmaceuticals (ETON) Stock Analysis: Exploring a 73.91% Upside Potential in the Rare Disease Market

Eton Pharmaceuticals, Inc. (NASDAQ: ETON) is attracting considerable attention in the healthcare sector, particularly among investors focused on specialty and generic drug manufacturers. Despite its relatively..

Weave Communications, Inc. (WEAV) Stock Analysis: Exploring a Potential 74% Upside in the Health Information Services Sector

Weave Communications, Inc. (NASDAQ: WEAV) is making waves in the health information services sector, offering investors intriguing growth potential. With a market capitalization of $391.69 million,..

Tectonic Therapeutic, Inc. (TECX) Stock Analysis: A Promising Biotech with a Potential 227% Upside

Tectonic Therapeutic, Inc. (NASDAQ: TECX), a pioneering force in the biotechnology sector, is making headlines with its strategic focus on the cutting-edge development of therapeutic proteins..

Fortrea Holdings Inc. (FTRE): Investor Outlook with a Promising 37.88% Potential Upside

Fortrea Holdings Inc. (FTRE), a burgeoning player in the healthcare sector, is capturing attention with its potential upside of 37.88%, as indicated by analyst ratings. Despite..

Xencor, Inc. (XNCR) Investor Outlook: Unpacking the 113% Potential Upside in Biotech Innovation

Xencor, Inc. (XNCR), a clinical-stage biopharmaceutical company, is attracting a lot of investor attention in the biotechnology sector, driven by its innovative approach to treating various..

Inventiva S.A. (IVA) Stock Analysis: A 136% Upside Potential Amidst Robust Revenue Growth

Inventiva S.A. (NASDAQ: IVA), a prominent player in the biopharmaceutical sector, is capturing investor attention with a remarkable 136% potential upside. With a current market capitalization..

Myriad Genetics, Inc. (MYGN) Stock Analysis: Navigating a 60% Upside Potential Amidst Financial Challenges

Myriad Genetics, Inc. (NASDAQ: MYGN) stands at a pivotal juncture as it navigates the complex landscape of molecular diagnostics and precision medicine. With a market capitalization..

Search

Funds

February 27, 2026

Search

Funds

February 27, 2026

FTSE 100

Funds